Therefore, the stabilization and activation of p53 function via nutlin or MI-219 may augment p53-suppressant effect via inhibition of the interaction between p53 and MDM2 protein during the blast crisis of CML [20]. This evidence concerns the gene MDM2 and chronic myelogenous leukemia, BCR-ABL1 positive.